Alix Ventures is a life science fund dedicated to supporting early-stage startups that are engineering biology to drive radical advances in human health. The firm typically invests in pre-seed, seed, and Series A rounds, leveraging its capital and networks to foster transformative companies within the life sciences sector, particularly those at the intersection of technology and biology.
Notable portfolio companies include 64x Bio, Endpoint Health, Teiko.bio, Xilis, and Zafrens, which have collectively raised significant funding to advance their innovative solutions. Alix Ventures prides itself on driving patient impact and offers unique value-add services that include strategic guidance and extensive industry connections to help startups navigate the complexities of the health sector.
Alix Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages